Dare Bioscience (DARE) Exchange Rate Effect (2017 - 2025)
Dare Bioscience's (DARE) quarterly Exchange Rate Effect came in at -$25657.0 in Q4 2025, up 61.23% YoY from -$15912.9 in Q4 2024, and down 474.01% on a QoQ basis from $6860.0 in Q3 2025.
Dare Bioscience (DARE) Exchange Rate Effect (2017 - 2025) Analysis & Trends
Dare Bioscience (DARE) has 9 years of Exchange Rate Effect data on file, last reported at -$25657.0 in Q4 2025.
- Quarterly Exchange Rate Effect rose 61.23% year-over-year to -$25657.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7186.0 (up 110.58% YoY) and the FY2025 annual result came in at $7186.0, up 110.58% from the prior year.
- Exchange Rate Effect declined to -$25657.0 in Q4 2025, from $6860.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $179429.0 in Q4 2022 to a low of -$230748.0 in Q3 2022.
- A 5-year average of -$16511.8 and a median of -$9015.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect slumped 9516.82% — and 2022, when it jumped 1063.84%.
- Tracing DARE's Exchange Rate Effect over 5 years: stood at $15417.0 in 2021, then jumped by 1063.84% to $179429.0 in 2022, then slumped by 67.34% to $58600.0 in 2023, then sank by 212.94% to -$66184.0 in 2024, then jumped by 61.23% to -$25657.0 in 2025.
- The last three Exchange Rate Effect figures came in at -$25657.0 (Q4 2025), $6860.0 (Q3 2025), and $12893.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | Dare Bioscience | 12.51 Mn | -108,646.28 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25,657.00 |
| Dec 31, 2025 | -25,657.00 |
| Sep 30, 2025 | 6,860.00 |
| Sep 30, 2025 | 6,860.00 |
| Jun 30, 2025 | 12,893.00 |
| Jun 30, 2025 | 12,893.00 |
| Mar 31, 2025 | 13,090.00 |
| Mar 31, 2025 | 13,090.00 |
| Dec 31, 2024 | -66,184.00 |
| Dec 31, 2024 | -66,184.00 |
| Sep 30, 2024 | 22,934.00 |
| Sep 30, 2024 | 22,934.00 |
| Jun 30, 2024 | 14,564.00 |
| Jun 30, 2024 | 14,564.00 |
| Mar 31, 2024 | -39,227.00 |
| Mar 31, 2024 | -39,227.00 |
| Dec 31, 2023 | 58,600.00 |
| Dec 31, 2023 | 58,600.00 |
| Sep 30, 2023 | -15,029.00 |
| Sep 30, 2023 | -15,029.00 |